Table 1

 Prevalence of additional cardiac abnormalities in patients with ventricular septal defect (VSD) with a comparison of frequencies between the adult and paediatric groups

Groupp Value
AllPaediatricAdult
ASD, atrial septal defect; CoA, coarctation of the aorta; IPS, infundibular pulmonary stenosis; NA, not applicable; NS, not significant; PBS, pulmonary branch stenosis; PDA, persistent ductus arteriosus.
IPS84 (5.80%)36 (4.31%)48 (7.84%)<0.005
Aortic prolapse52 (3.59%)11 (1.32%)41 (6.70%)<0.0001
Pulmonary valvar stenosis39 (2.69%)25 (2.99%)14 (2.29%)NS
Osteum secundum ASD32 (2.21%)23 (2.75%)9 (1.47%)NS
PDA27 (1.86%)24 (2.87%)3 (0.49%)<0.001
CoA22 (1.52%)20 (2.39%)2 (0.33%)<0.005
Osteum secundum ASD and PDA13 (0.90%)12 (1.44%)1 (0.16%)<0.05
Mitral regurgitation12 (0.83%)5 (0.60%)7 (1.14%)NS
IPS and aortic prolapse8 (0.55%)3 (0.36%)5 (0.82%)NS
Wolff-Parkinson-White syndrome5 (0.35%)3 (0.36%)2 (0.33%)NS
Aortic valvar stenosis3 (0.21%)2 (0.24%)1 (0.16%)NS
Pulmonary valvar stenosis and PDA3 (0.21%)3 (0.36%)0NA
PBS3 (0.21%)03 (0.49%)NA
CoA and IPS2 (0.14%)2 (0.24%)0NA
Aortic valvar stenosis and CoA2 (0.14%)2 (0.24%)0NA
IPS and osteum secundum ASD2 (0.14%)1 (0.12%)1 (0.16%)NA
PBS and ASD2 (0.14%)1 (0.12%)1 (0.16%)NA
Mitral stenosis2 (0.14%)02 (0.33%)NA
Dextrocardia2 (0.14%)02 (0.33%)NA
Aortic prolapse and IPS and CoA1 (0.07%)1 (0.12%)0NA
Pulmonary supravalvar stenosis1 (0.07%)1 (0.12%)0NA
Aortic valvar stenosis and PDA1 (0.07%)1 (0.12%)0NA
Mitral stenosis and CoA1 (0.07%)1 (0.12%)0NA
PDA and CoA1 (0.07%)1 (0.12%)0NA
IPS and PDA and aortic stenosis1 (0.07%)1 (0.12%)0NA